Switch to:
Cascadian Therapeutics Inc (NAS:CASC)
Sale Of Investment
$70.29 Mil (TTM As of Sep. 2016)

Cascadian Therapeutics Inc's sale of investment for the three months ended in Sep. 2016 was $14.82 Mil. It means Cascadian Therapeutics Inc gained $14.82 Mil from selling investments. Cascadian Therapeutics Inc's sale of investment for the trailing twelve months (TTM) ended in Sep. 2016 was $70.29 Mil.

Compared with last quarter ($18.36 Mil in Jun. 2016 ), Cascadian Therapeutics Inc gained less money from selling investments in Sep. 2016 ($14.82 Mil).


Definition

Sale of Investments represents cash inflow on the sale of investments in securities.

Cascadian Therapeutics Inc SaleOfInvestment for the trailing twelve months (TTM) ended in Sep. 2016 was 23.006 (Dec. 2015 ) + 14.104 (Mar. 2016 ) + 18.362 (Jun. 2016 ) + 14.818 (Sep. 2016 ) = $70.29 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms

Purchase of Investment, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Cascadian Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
SaleOfInvestment 43.2642.6634.251.8820.2156.6864.5268.3271.8686.03

Cascadian Therapeutics Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
SaleOfInvestment 15.1112.6632.0114.6512.3436.0423.0114.1018.3614.82
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK